E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 357.8 INR 1.83%
Market Cap: 256.8B INR
Have any thoughts about
Emcure Pharmaceuticals Ltd?
Write Note

Emcure Pharmaceuticals Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Emcure Pharmaceuticals Ltd
Accounts Payable Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
E
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Accounts Payable
â‚ą13.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Accounts Payable
â‚ą26.1B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Accounts Payable
â‚ą26.8B
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Accounts Payable
â‚ą57.3B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
13%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Accounts Payable
â‚ą21.9B
CAGR 3-Years
7%
CAGR 5-Years
2%
CAGR 10-Years
2%
M
Mankind Pharma Ltd
NSE:MANKIND
Accounts Payable
â‚ą11B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Emcure Pharmaceuticals Ltd's Accounts Payable?
Accounts Payable
13.1B INR

Based on the financial report for Mar 31, 2024, Emcure Pharmaceuticals Ltd's Accounts Payable amounts to 13.1B INR.

What is Emcure Pharmaceuticals Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 1Y
21%

Over the last year, the Accounts Payable growth was 21%.

Back to Top